跳到正文

Vivo Opportunity, LLC 内部人交易：近期 SEC Form 4 交易

过去 18 个月，Vivo Opportunity, LLC（CIK 1728970）在 1 家公司共报告 30 笔 SEC Form 4 内部人交易（最近一笔 2026-07-16）。

日期公司身份类型股数市值
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入4,882$7,567
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入493$764
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入13,761$21,330
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1,389$2,153
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入19$29
2026-07-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入2$3
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入545$839
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入55$85
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入3,946$6,116
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入398$617
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1,460$2,263
2026-07-02InMed Pharmaceuticals Inc. (INM)10% 以上股东买入147$228
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入51,056$79,647
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入5,154$8,040
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入30,882$52,191
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入3,118$5,269
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入16,164$25,377
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1,632$2,562
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入14,838$22,999
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1,498$2,322
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入20,753$31,545
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入2,095$3,184
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入7,069$10,957
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入714$1,107
2026-06-10InMed Pharmaceuticals Inc. (INM)10% 以上股东买入6,125$9,616

来源：SEC Form 4 申报文件 · 截至 2026-07-16